Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Session III: Clinical Aspects BMT I

Autologous and allogeneic stem cell transplantation in multiple myeloma

Bone Marrow Transplantation volume 25, pages S25–S26 (2000)Cite this article

Abstract

Multiple myeloma is still an incurable disease. The standard conventional chemotherapy comprises melphalan and prednisone (MP). Combination chemotherapy regimens could not improve the median survival of 36 months observed with MP. In the French IFM90 study, HD therapy with TBI plus melphalan 140 mg/m2 was shown to prolong overall survival and progression-free survival compared to conventional treatment. Nonetheless, most patients eventually succumb due to disease progression. Allogeneic transplantation may induce long-term remissions and even cure, but is hampered by a high transplantation-related mortality (TRM). Currently, efforts are made to reduce this TRM and to evaluate the graft-versus-myeloma effect. Bone Marrow Transplantation (2000) 25 , Suppl. 2, S25–S26.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

Author information

Authors and Affiliations

  1. Medizinische Klinik und Poliklinik V, Universität Heidelberg, Heidelberg, Germany

    H Goldschmidt, G Egerer & AD Ho

Authors
  1. H Goldschmidt
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G Egerer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. AD Ho
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Goldschmidt, H., Egerer, G. & Ho, A. Autologous and allogeneic stem cell transplantation in multiple myeloma. Bone Marrow Transplant 25 (Suppl 2), S25–S26 (2000). https://doi.org/10.1038/sj.bmt.1702348

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702348

Keywords

This article is cited by

Search

Advanced search

Quick links